Arlinda Lee of Canaccord Genuity, Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Increased Target from $22 to $24 on, Aug 15th, 2018.

Arlinda has made no other calls on CARA in the last 4 months.

There are 2 other peers that have a rating on CARA. Out of the 2 peers that are also analyzing CARA, 0 agree with Arlinda's Rating of Hold.

These are the ratings of the 2 analyists that currently disagree with Arlinda

Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $26 on, Wednesday, August 8th, 2018
Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Wednesday, May 23rd, 2018